Congress Materials

Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Y. GU, K. HUANG, X. SUN, X. ZHOU, R. SHEN, L. Young, A. CHHABRA, G. DIRUSSO, J. RUPON and I. WINBURN December 10, 2022 ASH 2022 Hemophilia

A Retrospective Cohort Study of Switching Patterns among Hemophilia A and B Patients using Optum Electronic Health Records (EHR) Database in the United States (US)

View Presentation
Poster
Deininger MW, Brummendorf TH, Lipton JH, Milojkovic D, Stenke L, Leip E, Purcell S, Viqueira A, Cortes JE December 10, 2022 ASH 2022 Hematology

Efficacy and Safety of Bosutinib Versus Imatinib by Charlson Comorbidity Index in Newly Diagnosed Patients With Chronic Myeloid Leukemia

View Presentation View Abstract Plain Language Summary
Oral Presentation
Bahlis N, Tomasson MH, Mohty M, Niesvizky R, Nooka A, Manier S, Maisel C, Jethava Y, Martinez-Lopez J, Prince HM, Arnulf B, Rodriguez-Otero P, Koehne G, Touzeau C, Raje N, Iida S, Raab M-S, Leip E, Sullivan S, Conte U, Viqueira A, Lesokhin A December 10, 2022 ASH 2022 Hematology

Efficacy and Safety of Elranatamab in Patients With Relapsed/Refractory Multiple Myeloma Naïve to B-cell Maturation Antigen (BCMA)-Directed Therapies: Results From Cohort A of the MagnetisMM-3 Study

View Presentation View Abstract Plain Language Summary
Poster
Grosicki S, Mellqvist U-H, Pruchniewski L, Crafoord J, Trudel S, Min C-K, White D, Alegre A, Hansson M, Ikeda T, Sunami K, Leip E, Kudla A, Finn G, Koh Y December 10, 2022 ASH 2022 Hematology

Elranatamab in Combination With Daratumumab for Patients With Relapsed/Refractory Multiple Myeloma: Results From the Phase 3 MagnetisMM-5 Study Safety Lead-In Cohort

View Presentation View Abstract Plain Language Summary
Oral Presentation
Raje NS, Bahlis NJ, Costello CL, Dholaria B, Solh M, Levy MY, Tomasson MH, Damore MA, Jiang S, Basu C, Skoura A, Chan EM, Trudel S, Jakubowiak A, Chu MP, Gasparetto C, Dalovisio A, Sebag M, Lesokhin AM December 10, 2022 ASH 2022 Hematology

Elranatamab, a BCMA-Targeted T-cell Engaging Bispecific Antibody, Induces Durable Clinical and Molecular Responses for Patients With Relapsed or Refractory Multiple Myeloma

View Presentation View Abstract Plain Language Summary
Poster
John Rasko, George Bashirians, Christos J Petropoulos, Terri Wrin, Yuvika Paliwal, Peter V Henstock, Suryanarayan Somanathan, Michelle Casey, Candida da Fonseca Pereira, Ian Winburn, Amit Chhabra December 10, 2022 ASH 2022 Hemophilia

Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy

View Presentation
Oral Presentation
Modupe Idowu; Thinh Nguyen; Erin Buckley; Rowan Brothers; Kobina Dufu; Eleanor Lisbon December 10, 2022 ASH 2022 Sickle Cell Disease

Pharmacodynamic Results From Phase 1 Studies Of GBT021601, A Next-Generation Hbs Polymerization Inhibitor For Treatment Of Sickle Cell Disease.

View Presentation
Poster
Gajra A, Kish JK, Russell-Smith A, Savill KMZ December 10, 2022 ASH 2022 Hematology

Real-World Observational Study of Outcomes for Acute Myeloid Leukemia (AML) in Patients Treated With Glasdegib or Venetoclax in US Community Oncology Practices

View Presentation View Abstract Plain Language Summary
Poster
Melanie E. Fields, Kaitlin L. Strumph, Manus J. Donahue, Mark Davis, Cesar Cisneros, Stephanie Bell, David Purdie, Emily Meier, Allison A. King December 10, 2022 ASH 2022 Sickle Cell Disease

Trials in Progress: Two Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials Investigating the Efficacy of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Patients With Sickle Cell Disease

View Presentation
Poster
Adam Giermasz, Nathan Visweshwar, Thomas J Harrington, Andrew D Leavitt, Barbara A Konkle, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M Cockroft, Annie Fang, Steven Arkin December 10, 2022 ASH 2022 Hemophilia

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

View Presentation